Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Wall St set for higher open after Micron revives AI optimism, upbeat economic data
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
Quest Diagnostics (DGX) PT Raised to $96 at Jefferies Following 4Q Earnings Report
January 27, 2017 9:03 AM ESTJefferies raised its price target on Quest Diagnostics (NYSE: DGX) to $96.00 (from $86.00) while maintaining a Hold rating. DGX posted its 5th consecutive quarter of positive organic volume growth, which yielded a $0.04/3% EPS beat on in-line EBITDA.
Analyst Brian Tanquilut commented, "We... More
Quest Diagnostics (DGX) Tops Q4 EPS by 4c; Guides In-Line
January 26, 2017 6:48 AM ESTQuest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.31, $0.04 better than the analyst estimate of $1.27. Revenue for the quarter came in at $1.86 billion versus the consensus estimate of $1.86 billion.
GUIDANCE:
Quest Diagnostics sees FY2017 EPS of $5.37-$5.52, versus the consensus of $5.45.... More
